Technetium Tc-99m Tilmanocept Patent Expiration

Technetium Tc-99M Tilmanocept was first introduced by Cardinal Health 414 Llc Cardinal Health Nuclear Pharmacy Services in its drug Lymphoseek Kit on Mar 13, 2013.


Technetium Tc-99m Tilmanocept Patents

Given below is the list of patents protecting Technetium Tc-99m Tilmanocept, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lymphoseek Kit US6409990 Macromolecular carrier for drug and diagnostic agent delivery May 12, 2025 Cardinal Health 414
Lymphoseek Kit US9439985 Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran Jan 30, 2029 Cardinal Health 414